CASµÇ¼ºÅ | ÖÐÎÄÃû | Ó¢ÎÄÃû | ·Ö×ӽṹʽ | ·Ö×Óʽ | ÏêÇé | ¹©Ó¦ÉÌ |
103300-74-9 | ËûÌæÈðÁÖ; (4S)-N-[(2S)-1-[(2S)-2-°±»ù¼×õ£»ùßÁ¿©Íé-1-»ù]-3-(3H-ßäßò-4-»ù)-1-Ñõ´ú±û-2-»ù]-1-¼×»ù-2,6-¶þ | Taltirelin; (4S)-N-[(2S)-1-[(2S)-2-Carbamoylpyrrolidin-1-yl]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-1-methyl-2,6-dioxo-1,3-diazinane-4-carboxamide | C17H23N7O5 | ÏêÇé | ¹©Ó¦ÉÌ | |
144143-96-4 | ¼×»ÇËáÒÀÆÕÂÞɳ̹; 4-[[2-¶¡»ù-5-(2-¼×õ£»ù-3-àç·Ô-2-»ù-±ûÏ©-1-»ù)-ßäßò-1-»ù]¼×»ù]±½¼×Ëá¼×»ÇËáÑÎ | Eprosartan mesylate; 4-[[2-Butyl-5-(2-carboxy-3-thiophen-2-yl-prop-1-enyl)-imidazol-1-yl]methyl]benzoic acid mesylate | C24H28N2O7S2 | ÏêÇé | ¹©Ó¦ÉÌ | |
168626-94-6 | N-[4-(2-¼×»ù-4,5-¶þÇâ-3H-ßäßò²¢[4,5-D][1]±½²¢µªÔÓ׿-6-¼×õ£»ù)±½»ù]-2-±½»ù±½¼×õ£°·ÑÎËáÑÎ | Conivaptan hydrochloride; Conivaptan hydrochloride; N-[4-(2-Methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide hydrochloride; (1,1'-Biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, monohydrochloride; Conivaptan HCl; Conivaptan hydrochloride [usan]; Unii-75L57R6X36; Vaprisol | C32H27ClN4O2 | ÏêÇé | ¹©Ó¦ÉÌ | |
140174-48-7 | 4-¼×õ£»ù-N,N-¶þ¼×»ù-1H-ßäßò-1-»Çõ£°· | N,N-Dimethyl 4-formyl-1H-imidazole-1-sulfonamide; 4-Formyl-N,N-dimethyl-1H-imidazole-1-sulfonamide; N,N-Dimethyl 4-formyl-1H-imidazole-1-sulfonamide | C6H9N3O3S | ÏêÇé | ¹©Ó¦ÉÌ | |
875337-44-3 | N-(3-·ú-4-(2-(1-¼×»ù-1H-ßäßò-4-»ù)àç·Ô²¢[3,2-B]ßÁà¤-7-Ñõ»ù)±½»ù°±»ùÁò´ú¼×õ£»ù)-2-±½ÒÒõ£°·; N-(3-·ú-4- | N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phen; N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide; MGCD-265 (Synonyms MGCD265); MGCD-265 | C26H20FN5O2S2 | ÏêÇé | ¹©Ó¦ÉÌ |